Vitreous traction after ozurdex injection

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 1, 2013, Pages 3-4

  Clemens, Christoph R ^a   Bertelmann, Thomas ^b   Meyer, Carsten H ^c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c Clinic Pallas   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

CENTRAL RETINA VEIN OCCLUSION; HUMAN; IMPLANT; LETTER; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA HOLE; TISSUE ADHESION; VISUAL ACUITY; VITREOMACULAR TRACTION; VITREORETINAL ADHESION; VITREOUS BODY;

DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; MACULA LUTEA; MACULAR EDEMA; MALE; RETINAL VEIN; RETINAL VEIN OCCLUSION; VITREOUS BODY;

EID: 84872838792     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0130     Document Type: Letter

References (3)

1. Bakri, S.J., and Omar, A.F. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion. J. Ocul. Pharmacol. Ther. 28:547-549, 2012
2. Bertelmann, T., Ki-cová, N., Irle, S., Sekundo, W., and Mennel, S. The vitreomacular interface in retinal vein occlusion. Acta Ophthalmol. 89:327-331, 2011
3. Meyer, C.H., Klein, A., Alten, F., Liu, Z., Stanzel, B.V., Brinkmann, C.K., and Helb, H.M. Release and velocity of micronized dexamethasone intravitreal implants with an intravitreal drug delivery system - kinematic analysis with a high speed camera. Retina. 2012. [Epub ahead of print] DOI: 10.1097/IAE.0b013e31825699e5